Kolon Life Science to Transfer Technology and Rights Worth 17 Billion KRW
Kolon Life Science announced on June 26 that it will transfer comprehensive technology and rights related to 'mPPO' to Kolon Industries. The transferred technologies include all processes, analytical techniques, quality control, production technology, and patents related to mPPO. The contract amount is approximately 17 billion KRW. The contract period is from June 30, 2025, to July 31, 2025.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
